Gastroenteropancreatic neuroendocrine neoplasms are a heterogenous group of rare
neoplasms that are increasingly being discovered, often incidentally, throughout the …

The present paper reflects the position of the Italian Association for Neuroendocrine Tumors
(Itanet), the Italian Society of Gastroenterology (SIGE), and the Italian Society of Digestive …

Background Duodenal neuroendocrine tumors (dNETs) are rare, and their management is
not well-defined. National Comprehensive Cancer Network (NCCN) guidelines recommend …

Duodenal neuroendocrine tumors (d-NETs)≤ 10 mm in size, confined to the submucosal
layer, without lymph node or distant metastasis, can be treated safely and effectively by …

Background. The optimal management of duodenal neuroendocrine neoplasms (dNENs)
sized 10–20 mm remains controversial and although endoscopic resection is increasingly …

Introduction Studies conflict on whether sex influences survival in gastroenteropancreatic
neuroendocrine tumors (GEP-NETs). GEP-NETs express receptors and genes responsive to …

BACKGROUND Duodenal neuroendocrine tumours (DNETs) are rare neoplasms. However,
the incidence of DNETs has been increasing in recent years, especially as an incidental …

Introduction Recommendations for resection technique of duodenal neuroendocrine
neoplasms (D-NEN) with a size between 10 and 20 mm are lacking. The primary aim was to …

Intestinal neuroendocrine tumors (NETs) arise from the diffuse endocrine system present
throughout its submucosal lining. These tumor cells are typically well-differentiated, slow …

The incidence of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) has increased
over the last several decades. In general, NETs are slow-growing neoplasms and the data …